Europe Artificial Organs And Bionic Implants Market Size (2024 - 2029)

Europe Artificial Organs and Bionic Implants Market Analysis

The Europe Artificial Organs And Bionic Implants Market size is estimated at USD 8.65 billion in 2024, and is expected to reach USD 12.35 billion by 2029, growing at a CAGR of 7.35% during the forecast period (2024-2029).

Factors such as the rising incidence of organ failures and disabilities, scarcity of donor organs, and technological advancements leading to enhanced applications are anticipated to drive market growth over the forecast period.

Major organs in a body, such as kidneys, liver, lungs, heart, central nervous system, and hematologic system, tend to fail among the target population. In Europe, the number of organ failures has been increasing consistently over the past few decades, but the number of organ donors remains few. This is creating demand for artificial organs in the region. For instance, a study published in the World Congress of Nephrology in April 2024 predicts a significant rise in advanced-stage chronic kidney disease cases (up to 59.3%) by 2032 across eight major countries, including the United Kingdom, Spain, Germany, and the Netherlands.

Furthermore, according to the same source, dialysis requirements are expected to surge by over 75%, increasing the economic and environmental burden. These factors are expected to create opportunities for adopting artificial organs and bionic implants, specifically artificial kidneys, to address the growing CKD crisis. Hence, the market is expected to grow considerably over the analysis period.

With a strong focus on research and development, coupled with growing demand due to an aging population and rising chronic diseases, this market is expected to experience significant growth in the coming years. For instance, according to the European Union in May 2023, the Breakthrough Technologies for an Implantable Artificial Kidney project funded with EUR 3.38 million (USD 3.63 million) by the Horizon European Innovation Council (EIC) in 2022 exemplified the ongoing research efforts toward a viable alternative. This indicates a strong focus on developing implantable artificial kidneys in Europe. Therefore, the European artificial organs and bionic implants market is poised for significant growth, driven by increasing funding for research.

In addition, the development of innovative dialysis technologies, including portable, wearable, and implantable artificial kidney systems, is set to transform this market, offering more effective and patient-friendly solutions. For instance, a study published in Nature Reviews Nephrology in June 2023 examined the integration of bioartificial kidneys (BAKs) with advanced membranes in the European market. This study emphasized BAKs, which merge artificial membranes with functional kidney cells and aim to restore critical biological functions that are typically managed through conventional dialysis. These functions include erythropoietin production, which is vital for red blood cell production, and vitamin D synthesis, which is essential for calcium metabolism and bone health. The study underscores the potential of these bioartificial systems to enhance patient outcomes by offering a more physiologically relevant alternative to traditional dialysis methods.

Thus, innovations such as portable and wearable artificial kidneys, advanced dialysis membranes, and bioartificial kidneys are poised to meet the growing demand, and they are anticipated to contribute to the growth of the artificial organs and bionic implants market over the forecast period. However, expensive procedures and fear of device malfunction and its consequences are expected to hinder the market's growth.

Europe Artificial Organs and Bionic Implants Industry Segmentation

As per the scope of the report, artificial organs are mechanical devices that can temporarily or permanently substitute for a body organ. These devices can replicate or augment the organ's natural function. Bionics refers to the replacement or improvement of body parts by mechanical means.

The European artificial organs and bionic implants market is segmented by type (artificial organs and bionics) and geography (Germany, the United Kingdom, France, Italy, Spain, and Rest of Europe). The report offers market sizes and forecasts in terms of value (USD) for all the above segments.